Ingredient solutions firm Ingredion misses Q2 revenue estimates

Ingredion

01/08/2025 11:16

Overview

Ingredion Q2 2025 revenue decreased 2%, missing analyst expectations

Adjusted EPS for Q2 2025 beats consensus, reflecting operational resilience

Company improves full-year EPS guidance, indicating confidence in business model

Outlook

Ingredion expects full-year 2025 reported EPS of $11.25 to $11.75

Full-year 2025 adjusted EPS expected between $11.10 and $11.60

Company anticipates flat full-year 2025 net sales

Full-year 2025 operating income expected to rise mid-single digits

Result Drivers

TEXTURE & HEALTHFUL SOLUTIONS - Segment saw 29% operating income growth due to increased sales volume and lower raw material costs

LATAM CHALLENGES - Segment impacted by foreign exchange rates and Argentina joint venture performance

U.S./CANADA IMPACT - Mechanical fire and reduced industrial demand led to decreased operating income

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Sales
Miss
$1.83 bln
$1.89 bln (5 Analysts)
Q2 Adjusted EPS
Beat
$2.87
$2.79 (5 Analysts)
Q2 EPS
$2.99


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the food processing peer group is "buy"

Wall Street's median 12-month price target for Ingredion Inc is $147.00, about 10.5% above its July 31 closing price of $131.54

The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 12 three months ago

Press Release: ID:nGNX17ZRNf

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)